Whanganui Chronicle
  • Whanganui Chronicle home
  • Latest news
  • Sport
  • Business
  • Opinion
  • Lifestyle
  • Property
  • Death notices
  • Classifieds

Subscriptions

  • Herald Premium
  • Viva Premium
  • The Listener
  • BusinessDesk

Sections

  • Latest news
  • On The Up
  • Sport
  • Business
  • Opinion
  • Lifestyle
  • Property
    • All Property
    • Residential property listings
  • Rural
    • All Rural
    • Dairy farming
    • Sheep & beef farming
    • Horticulture
    • Animal health
    • Rural business
    • Rural life
    • Rural technology

Locations

  • Taranaki
  • National Park
  • Whakapapa
  • Ohakune
  • Raetihi
  • Taihape
  • Marton
  • Feilding
  • Palmerston North

Media

  • Video
  • Photo galleries
  • Today's Paper - E-Editions
  • Photo sales
  • Classifieds

Weather

  • New Plymouth
  • Whanganui
  • Palmertson North
  • Levin

NZME Network

  • Advertise with NZME
  • OneRoof
  • Driven Car Guide
  • BusinessDesk
  • Newstalk ZB
  • Sunlive
  • ZM
  • The Hits
  • Coast
  • Radio Hauraki
  • The Alternative Commentary Collective
  • Gold
  • Flava
  • iHeart Radio
  • Hokonui
  • Radio Wanaka
  • iHeartCountry New Zealand
  • Restaurant Hub
  • NZME Events

SubscribeSign In
Advertisement
Advertise with NZME.
Home / Whanganui Chronicle

Keytruda news thrills advocate

By Anne-Marie McDonald
Whanganui Chronicle·
29 Jun, 2016 08:51 PM2 mins to read

Subscribe to listen

Access to Herald Premium articles require a Premium subscription. Subscribe now to listen.
Already a subscriber?  Sign in here

Listening to articles is free for open-access content—explore other articles or learn more about text-to-speech.
‌
Save

    Share this article

Ross Fallen

Ross Fallen

A Whanganui man who campaigned for funding for a melanoma drug is delighted the Government has decided to fund the treatment.

Pharmaceutical company MSD announced on Tuesday it had signed a provisional agreement with Pharmac, the government drug-buying agency, to fully fund pembrolizumab, known as Keytruda.

The agreement is subject to approval from Pharmac's board.

Keytruda is used in the treatment of melanoma which cannot be removed by surgery alone or when it has spread to multiple sites in the body.

The news was welcomed by Ross Fallen, who was at Parliament in March when an 11,000-signature petition calling for the Government to boost funding to Pharmac so it could subsidise the drug was presented to Health Minister Jonathan Coleman.

Advertisement
Advertise with NZME.
Advertisement
Advertise with NZME.

"I'm over the moon about this," Mr Fallen said.

He was especially pleased to know that MSD would supply a bridging programme for patients who were either paying for the drug themselves, or who wanted to start taking the drug.

The bridging programme starts immediately and runs until September 1, when the Pharmac funding kicks in.

Advertisement
Advertise with NZME.

The programme will be paid for by MSD.

"Good people have died because they can't afford this drug.

"It's inhumane.

"Many New Zealanders can't afford to pay for Keytruda themselves."

Mr Fallen said he hoped this would be the start of funding for other important drug therapies.

"I recognise that Pharmac can't afford to pay for everything. But I got behind this campaign because it affected me personally."

Mr Fallen has had two small melanomas removed, and has a long family history of cancers.

He said he was grateful to the Government for "stepping forward on this issue", the Labour Party for putting pressure on the Government, and petition organiser Leisa Renwick.

Save

    Share this article

Latest from Whanganui Chronicle

Whanganui Chronicle

'Please do not do it': Man inflicted intense pain on woman during violation

04 Jul 08:00 AM
Whanganui Chronicle

'Evocative tribute': Exhibition explores Whanganui's spiritual heritage

04 Jul 03:00 AM
Whanganui Chronicle

Central North Island feels impact of heavy rain

04 Jul 02:44 AM

There’s more to Hawai‘i than beaches and buffets – here’s how to see it differently

sponsored
Advertisement
Advertise with NZME.

Latest from Whanganui Chronicle

'Please do not do it': Man inflicted intense pain on woman during violation

'Please do not do it': Man inflicted intense pain on woman during violation

04 Jul 08:00 AM

Judge Tompkins said Michael Mead, 64, posed a 'very high risk' in the future.

'Evocative tribute': Exhibition explores Whanganui's spiritual heritage

'Evocative tribute': Exhibition explores Whanganui's spiritual heritage

04 Jul 03:00 AM
Central North Island feels impact of heavy rain

Central North Island feels impact of heavy rain

04 Jul 02:44 AM
Premium
Tradie's remarkable revival of long-lost NZ clothing brand from his backyard shed

Tradie's remarkable revival of long-lost NZ clothing brand from his backyard shed

03 Jul 10:43 PM
From early mornings to easy living
sponsored

From early mornings to easy living

NZ Herald
  • About NZ Herald
  • Meet the journalists
  • Newsletters
  • Classifieds
  • Help & support
  • Contact us
  • House rules
  • Privacy Policy
  • Terms of use
  • Competition terms & conditions
  • Our use of AI
Subscriber Services
  • Whanganui Chronicle e-edition
  • Manage your print subscription
  • Manage your digital subscription
  • Subscribe to Herald Premium
  • Subscribe to the Whanganui Chronicle
  • Gift a subscription
  • Subscriber FAQs
  • Subscription terms & conditions
  • Promotions and subscriber benefits
NZME Network
  • Whanganui Chronicle
  • The New Zealand Herald
  • The Northland Age
  • The Northern Advocate
  • Waikato Herald
  • Bay of Plenty Times
  • Rotorua Daily Post
  • Hawke's Bay Today
  • Viva
  • NZ Listener
  • Newstalk ZB
  • BusinessDesk
  • OneRoof
  • Driven Car Guide
  • iHeart Radio
  • Restaurant Hub
NZME
  • NZME Events
  • About NZME
  • NZME careers
  • Advertise with NZME
  • Digital self-service advertising
  • Book your classified ad
  • Photo sales
  • © Copyright 2025 NZME Publishing Limited
TOP